Peptide questions · Semaglutide
How long does semaglutide take to work?
Reviewed Evidence: EstablishedPublished by PepVault
Semaglutide’s onset is days–2 weeks, its peak effect comes at 60–68 weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
The timeline’s basis: Multiple Phase III RCTs (STEP 1–5). FDA-approved. Timelines are for weight management dose (2.4mg) on the label's titration.
Semaglutide week by week
The library places six of its research notes on semaglutide on the days they cover, from day 1 to day 364 and on: 6 on randomized trials.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–28 (weeks 1–4) | Gut is adapting | Randomized trial |
| Days 29–56 (weeks 5–8) | Appetite shifts are real now | Randomized trial |
| Days 57–112 (weeks 9–16) | Clinically useful weight loss kicks in | Randomized trial |
| Days 113–140 (weeks 17–20) | Max submaximal step | Randomized trial |
| Days 141–364 (weeks 21–52) | Full dose — the working dose | Randomized trial |
| From day 365 on | Plateau territory — new baseline | Randomized trial |

Model. Individual results vary.
The semaglutide timeline’s milestones
The library’s timeline for semaglutide marks 10 points from week 1 to week 52, backed by clinical trial data overall.
- Week 1: Commonly reported: appetite dropping, with nausea worst in the first days
- Week 2: Commonly reported: food noise going quiet and portions shrinking without effort
- Week 4: First escalation (0.5mg) — ~2–4% body weight loss
- Week 8: ~3–5% loss, appetite regulation feeling more natural
- Week 12: ~5–8% loss — glucose and triglycerides improving
- Week 16: Approaching full dose; commonly reported: food noise much quieter
- Week 20: ~8–10% loss — sustained, not plateauing
- Week 28: ~10–12% loss, cardiovascular markers improved
- Week 40: ~12–14% loss — new metabolic set point establishing
- Week 52: One year — nearing the trial average of ~15% (lowest point near week 60)
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why semaglutide takes that long
Semaglutide’s half-life is about 7 days (168 hours), so one dose is about 96.9% cleared after 35 days.
On its schedule (Weekly SubQ) the doses overlap, and the level of semaglutide keeps climbing for about 28–35 days before it levels off, so the first 28–35 days run below the level the later weeks hold.
The notes on semaglutide follow the trials’ dose steps, 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.
Semaglutide against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, semaglutide among them; 15 of the others share its onset of days–2 weeks.
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does semaglutide take to work?
Semaglutide’s onset is days–2 weeks, its peak effect comes at 60–68 weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
When does semaglutide reach its peak effect?
By the library’s timeline, semaglutide’s peak effect comes at 60–68 weeks, backed by clinical trial data.
How long is semaglutide usually run?
The library’s timeline gives semaglutide’s typical duration as ongoing; its cycle note says: FDA-approved for ongoing use.
What does the library say about the first days on semaglutide?
Its first note on semaglutide, for days 1–28 (weeks 1–4), is “Gut is adapting”, resting on randomized trials.